Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 379

Twin and Triplet Pregnancies

NICE guideline [NG137] Twin and triplet pregnancy. Last updated: Apr 2024.

RCOG Monochorionic Twin Pregnancy, Management – 2024 Partial Update (Green-top Guideline No. 51). Last reviewed: Feb 2024.

RCOG Patient information Multiple pregnancy: having more than one baby. Last reviewed: 2023.

Epidemiology

Twins or triplets occur in approximately 1 in 60 pregnancies.

The incidence of multiple pregnancies has risen over the past 30 years, primarily driven by:

  • Use of ARTs (e.g. IVF)
  • Advanced maternal age (women are deferring pregnancy to an older age)

Identical vs Non-Identical Twins

Twins or triples can be identical or non-identical:

Type Mechanism Clinical phenotype
Identical (monozygotic) twin ONE egg fertilised by ONE sperm, then splits into TWO after fertilisation Since they originate from the same egg → identical genes

  • Same sex
  • Looks the same (identical)

*Monochorionic pregnancies are always identical (monozygotic) twins

Non-identical (dizygotic) twin DIFFERENT egg fertilised by DIFFERENT sperm Different egg → different genes

  • They won’t look any more similar to each other than any other brothers or sisters

Types of Twin Pregnancy

There are 3 main types of twin pregnancies:

Type Prevalence Description Identical vs non-identical
Dichorionic diamniotic (DCDA) Most common (~80%) Each baby has its own placenta

Each baby has its own amniotic sac

These babies are more likely to be non-identical (dizygotic)
Monochorionic diamniotic (MCDA) ~15% Both babies share a single placenta

Each baby has its own amniotic sac

These babies are always identical (monozygotic), as they share a placenta
Monochorionic monoamniotic (MCMA) <1% Both babies share a single placenta

Both within the same amniotic sac

The classification systems are fundamentally similar for triplet pregnancies, but are more complex due to the higher number of possible combinations.

Both twin and triplet pregnancies are classified based on the exact same concepts of chorionicity (the number of outer membranes or placentas) and amnionicity (the number of inner membranes or amniotic sacs).

Information on the classification of triplet pregnancies is omitted as it is very rare and much less likely to be encountered or examined, compared to twin pregnancies.

Risks and Complications

Type Risks and complications
Dichorionic diamniotic (DCDA) General risks that apply to all multiple pregnancies:

  • Preterm birth (~60% cases)
  • Fetal growth restriction
  • Maternal complications – ↑ risk of
    • Pre-eclampsia
    • Anaemia
    • Postpartum haemorrhage (over-distended uterus → risk of atony)

DCDA twins have the lowest overall risk compared to other types.

Monochorionic diamniotic (MCDA) Carries all the general risks that apply to all multiple pregnancies (see the DCDA row).

PLUS additional risks from a shared placenta:

  • Twin-to-twin transfusion syndrome
  • Selective growth restriction
  • Co-twin demise consequences
Monochorionic monoamniotic (MCMA) Carries all the risks associated with MCDA (see MCDA row).

PLUS additional risks from a shared amniotic sac:

  • Umbilical cord entanglement – almost always present
  • High risk of intrauterine death
  • Highest rate of co-twin demise consequences

The exact same concepts and complications apply to triplet pregnancies, and the risks are significantly amplified. This is again omitted as it is very rare and much less likely to be encountered or examined, compared to twin pregnancies.

Twin-to-Twin Transfusion Syndrome (TTTS)

Definition A severe complication specific to monochorionic pregnancies, where babies share a single placenta and blood supply

It occurs when blood flow between the babies becomes unbalanced due to shared blood vessels (anastomoses) on the placenta, as a result:

  • One baby (donor) receives too little blood
  • One baby (recipient) receives an excessive amount of blood
Risk TTTS complicates ~15-20% of all monochorionic twin pregnancies:

  • Most commonly seen in MCDA twin pregnancies
  • Very rarely seen in MCMA twin pregnancies
Maternal symptoms Often a sudden onset of:

  • Increase in abdominal size or swelling
  • Dyspnoea
  • Noticeable change or reduction in fetal movements
Fetal complications Consequences of the donor twin (receives too little blood)

  • Oligohydramnios
  • Anuria
  • Growth and vascular restrictions

Consequences of the recipient twin (receives too much blood)

  • Polyhydramnios
  • Circulatory overload and high-output heart failure
  • Hydrops fetalis
Diagnosis TTTS can be detected on ultrasound (see the monitoring and investigation section below for more details)

  • Key feature: significant discordance in amniotic fluid volumes between the 2 sacs
  • Oligohydramnios in the donor sac and polyhydramnios in the recipient sac
Management Primary management (for TTTS diagnosed <26 weeks): fetoscopic laser ablation of the placental blood vessels

Alternatives:

  • Amnioreduction (draining excessive amniotic fluid) may be considered if laser ablation is not appropriate or if the diagnosis is made >26 weeks
  • Selective termination of 1 fetus (with cord occlusion techniques) – esp. if there is already severe cerebral damage in 1 twin

Timing of birth:

  • Planned preterm birth is typically recommended between 34-36+6 weeks

Surveillance and Testing

Standard antenatal advice applies to all multiple pregnancies (including dietary guidance, lifestyle recommendations, booking bloods, anomaly scanning – see the Antenatal Care article).

However, the maternal and fetal risks are significantly elevated, necessitating the following additional measures.

Identification of Twin / Triplet Pregnancies

Multiple pregnancies are typically detected during the routine dating scan (ultrasound) between 11 and 14 weeks

This scan also helps establish the chorionicity (number of shared placentas) and amnionicity (number of shared amniotic sacs), which define the exact subtype of the multiple pregnancy:

  • Lambda sign (or twin peak sign): indicates dichorionic pregnancy (i.e. DCDA if it’s a twin pregnancy)
  • T-sign: indicates monochorionic pregnancy (i.e. MCDA or MCMA if it’s a twin pregnancy)

Extended Fetal Ultrasound Surveillance

Extended ultrasounds are necessary in the 2nd and 3rd trimester due to the high risk of fetal growth restriction and to screen for complications like twin-to-twin transfusion syndrome.

Type of pregnancy Frequency of scans
DCDA twins Every 4 weeks starting from 24 weeks
Monochorionic twins (MCDA or MCMA) Every 2 weeks starting from 16 weeks
ALL triplet pregnancies Every 2 weeks starting from 20 weeks for uncomplicated trichorionic triplets and 16 weeks for dichorionic or monochorionic triplets

Specific features evaluated during ultrasound surveillance:

  • Estimated fetal weight and discordance
  • Screening for twin-to-twin transfusion syndrome
    • Amniotic fluid levels in each sac
    • Fetal bladders (lack of urine in 1 bladder is a sign)
  • Umbilical artery doppler
  • Middle cerebral artery peak systolic velocity

Preterm Birth Screening

Routine preterm birth screening is required due to the significantly higher risk of spontaneous preterm birth:

  • Offer a single ultrasound scan to measure cervical length between 16-20 weeks
  • If cervix is short (≥25 mm) → vaginal progesterone once daily until 34 weeks

Do NOT use fetal fibronectin testing alone or home uterine activity monitoring to predict preterm birth.

Do NOT routinely offer bed rest, oral tocolytics, arabin pessaries, or cervical cerclage to prevent preterm birth.

Management

Planned Delivery Timing

Due to increased risk of fetal death in 3rd trimester, planned early birth is universally recommended, assuming uncomplicated:

Pregnancy type Planned birth timing
Dichorionic diamniotic (DCDA) twins 37 weeks
Monochorionic diamniotic (MCDA) twins 36 weeks
Monochorionic monoamniotic (MCMA) twins 32-33+6 weeks
Trichorionic or dichorionic triplets 35 weeks

Mode of Birth

Pregnancy type Mode of birth
Dichorionic diamniotic (DCDA) twins If the pregnancy is over 32 weeks:

  • First twin is cephalic presentation with no significant size discordance → both planned vaginal birth and Caesarean section are safe choices
    • However, individuals planning a vaginal birth should be counselled that more than a third will still go on to need a caesarean section, and a small number may need an emergency caesarean
  • First twin is NOT cephalic → planned Caesarean section
Monochorionic diamniotic (MCDA) twins
Monochorionic monoamniotic (MCMA) twins Planned Caesarean section is routinely offered
Triplets

Intrapartum Care

Key principles include:

  • Epidural analgesia is actively recommended for vaginal twin birth (improves success rate of any required assisted vaginal birth and allows rapid emergency Caesarean section if needed)
  • Continuous CTG is offered instead of intermittent auscultation
  • Bedside ultrasound: at the onset of established labour, a portable ultrasound is used to confirm fetal presentations and locate the hearts
  • Active management of 3rd stage of labour with uterotonic drugs (e.g. oxytocin) – due to increased risk of postpartum haemorrhage

References

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.